Background Universal antiretroviral therapy (ART) with annual population testing and a
multidisease, patient-centered strategy could reduce new human immunodeficiency virus (HIV) …

Background Antiretroviral therapy (ART) is indicated during tuberculosis treatment in patients
infected with human immunodeficiency virus type 1 (HIV-1), but the timing for the initiation …

Tuberculosis remains an important problem in patients with human immunodeficiency virus (HIV)
infection in the United States, with an estimated 6000 to 9000 new cases annually. The …

Background Antiretroviral therapy that reduces viral replication could limit the transmission
of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. Methods In nine …

Background The new protease inhibitors are potent inhibitors of the human immunodeficiency
virus (HIV), and in combination with other antiretroviral drugs they may be able to cause …

Traditional infection-control and public health strategies rely heavily on early detection of
disease to contain spread. When Covid-19 burst onto the global scene, public health officials …

Background The use of either efavirenz or lopinavir–ritonavir plus two nucleoside reverse-transcriptase
inhibitors (NRTIs) is recommended for initial therapy for patients with human …

Background Combination antiretroviral therapy with indinavir, zidovudine, and lamivudine
can suppress the level of human immunodeficiency virus (HIV) RNA in plasma below the …

Importance Antiretroviral treatment (ART) is now recommended for all HIV-positive persons.
UNAIDS has set global targets to diagnose 90% of HIV-positive individuals, treat 90% of …

Background In Africa, up to 30% of HIV-infected patients who are clinically eligible for antiretroviral
therapy (ART) do not start timely treatment. We assessed the effects of an intervention …